Pfizer Takes On Gilead, Novartis With New Deal In Cancer Drugs
Dow Jones stock Pfizer is teaming up with a group of former Kite executives to take on Gilead and Novartis in advanced cancer treatments.
What to Read Next
Targeting 'bubble baby' disease, this gene therapy company is planting a flag in the East Bay
American City Business Journals